Treating Bone Disease Improves Myeloma Outcomes
All patients with myeloma should be treated for bone disease.
Although there are effective agents to treat bone disease in patients with myeloma, many patients are not receiving them, explained G. David Roodman, MD, PhD, the Kenneth Wiseman Professor of Medicine at Indiana University School of Medicine.
Almost all guidelines now recommend that patients with myeloma are treated for bone disease, regardless of whether or not legions appear on X-rays, because these therapies can improve quality of life and extend survival, Roodman said.
Survival Benefit, Durable Responses Continue at 3 Years With Liso-cel in Second-line LBCL
July 15th 2024Three-year findings from the TRANSFORM trial provide further evidence that liso-cel should be considered as the new standard of care along with other CAR T-cell therapies for patients with primary refractory or relapsed LBCL, an expert said.
